Penserra Capital Management LLC Compass Pathways PLC Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.76 - $14.18 $15,879 - $33,308
-2,349 Reduced 8.1%
26,651 $288,000
Q1 2022

May 13, 2022
BUY
$11.13 - $23.04 $91,844 - $190,126
8,252 Added 39.77%
29,000 $277,000
Q4 2021

Feb 15, 2022
BUY
$21.81 - $48.96 $86,411 - $193,979
3,962 Added 23.6%
20,748 $458,000
Q3 2021

Nov 15, 2021
BUY
$29.03 - $38.62 $145,295 - $193,293
5,005 Added 42.48%
16,786 $501,000
Q2 2021

Aug 12, 2021
BUY
$32.29 - $39.68 $380,408 - $467,470
11,781 New
11,781 $449,000

Others Institutions Holding CMPS

# of Institutions
151
Shares Held
33.6M
Call Options Held
536K
Put Options Held
582K
View Full List

About COMPASS Pathways plc

CMPS Quotes by TradingView
  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email